Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
12 03 2020
Historique:
received: 25 07 2019
accepted: 17 02 2020
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 28 7 2020
Statut: epublish

Résumé

Macrophages have important protective functions during infection with herpes simplex virus type 1 (HSV-1). However, molecular mechanisms that restrict viral propagation and protect from severe disease are unclear. Here we show that macrophages take up HSV-1 via endocytosis and transport the virions into multivesicular bodies (MVBs). In MVBs, acid ceramidase (aCDase) converts ceramide into sphingosine and increases the formation of sphingosine-rich intraluminal vesicles (ILVs). Once HSV-1 particles reach MVBs, sphingosine-rich ILVs bind to HSV-1 particles, which restricts fusion with the limiting endosomal membrane and prevents cellular infection. Lack of aCDase in macrophage cultures or in Asah1

Identifiants

pubmed: 32165633
doi: 10.1038/s41467-020-15072-8
pii: 10.1038/s41467-020-15072-8
pmc: PMC7067866
doi:

Substances chimiques

Acid Ceramidase EC 3.5.1.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1338

Références

Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723–737 (2011).
pubmed: 21997792 pmcid: 3422549 doi: 10.1038/nri3073
Honke, N. et al. Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat. Immunol. 13, 51–57 (2011).
pubmed: 22101728 doi: 10.1038/ni.2169 pmcid: 22101728
Cervantes-Barragan, L. et al. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 182, 1099–1106 (2009).
pubmed: 19124753 doi: 10.4049/jimmunol.182.2.1099 pmcid: 19124753
Lang, P. A. et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 52, 25–32 (2010).
pubmed: 20578253 doi: 10.1002/hep.23640 pmcid: 20578253
Jenne, C. N. & Kubes, P. Immune surveillance by the liver. Nat. Immunol. 14, 996–1006 (2013).
pubmed: 24048121 doi: 10.1038/ni.2691 pmcid: 24048121
Wardle, E. N. Kupffer cells and their function. Liver 7, 63–75 (1987).
pubmed: 3302581 doi: 10.1111/j.1600-0676.1987.tb00319.x pmcid: 3302581
Karasneh, G. A. & Shukla, D. Herpes simplex virus infects most cell types in vitro: clues to its success. Virol. J. 8, 481 (2011).
pubmed: 22029482 pmcid: 3223518 doi: 10.1186/1743-422X-8-481
Nicola, A. V. Herpesvirus entry into host cells mediated by endosomal low pH. Traffic 17, 965–975 (2016).
pubmed: 27126894 pmcid: 5444542 doi: 10.1111/tra.12408
Agelidis, A. M. & Shukla, D. Cell entry mechanisms of HSV: what we have learned in recent years. Future Virol. 10, 1145–1154 (2015).
pubmed: 27066105 pmcid: 4822157 doi: 10.2217/fvl.15.85
Weed, D. J. & Nicola, A. V. Herpes simplex virus membrane fusion. Adv. Anat. Embryol. Cell Biol. 223, 29–47 (2017).
pubmed: 28528438 pmcid: 5869023 doi: 10.1007/978-3-319-53168-7_2
Sodeik, B., Ebersold, M. W. & Helenius, A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136, 1007–1021 (1997).
pubmed: 9060466 pmcid: 2132479 doi: 10.1083/jcb.136.5.1007
Mabit, H. et al. Intact microtubules support adenovirus and herpes simplex virus infections. J. Virol. 76, 9962–9971 (2002).
pubmed: 12208972 pmcid: 136514 doi: 10.1128/JVI.76.19.9962-9971.2002
Ojala, P. M., Sodeik, B., Ebersold, M. W., Kutay, U. & Helenius, A. Herpes simplex virus type 1 entry into host cells: reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell Biol. 20, 4922–4931 (2000).
pubmed: 10848617 pmcid: 85943 doi: 10.1128/MCB.20.13.4922-4931.2000
Flatt, J. W. & Greber, U. F. Viral mechanisms for docking and delivering at nuclear pore complexes. Semin. Cell Dev. Biol. 68, 59–71 (2017).
pubmed: 28506891 doi: 10.1016/j.semcdb.2017.05.008 pmcid: 28506891
Yamauchi, Y. & Greber, U. F. Principles of virus uncoating: cues and the snooker ball. Traffic 17, 569–592 (2016).
pubmed: 26875443 doi: 10.1111/tra.12387 pmcid: 26875443
Virgin, H. W. The virome in mammalian physiology and disease. Cell 157, 142–150 (2014).
pubmed: 24679532 pmcid: 3977141 doi: 10.1016/j.cell.2014.02.032
Bigalke, J. M. & Heldwein, E. E. Nuclear exodus: herpesviruses lead the way. Annu. Rev. Virol. 3, 387–409 (2016).
pubmed: 27482898 pmcid: 5065387 doi: 10.1146/annurev-virology-110615-042215
Mettenleiter, T. C. Herpesvirus assembly and egress. J. Virol. 76, 1537–1547 (2002).
pubmed: 11799148 pmcid: 135924 doi: 10.1128/JVI.76.4.1537-1547.2002
Yamauchi, Y., Kiriyama, K., Kimura, H. & Nishiyama, Y. Herpes simplex virus induces extensive modification and dynamic relocalisation of the nuclear mitotic apparatus (NuMA) protein in interphase cells. J. Cell Sci. 121, 2087–2096 (2008).
pubmed: 18505791 doi: 10.1242/jcs.031450 pmcid: 18505791
Lee, D. H. & Ghiasi, H. Roles of M1 and M2 macrophages in herpes simplex virus 1 infectivity. J. Virol. 91, e00578–17 (2017).
pubmed: 28490589 pmcid: 5512262
Rasmussen, S. B. et al. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J. Virol. 81, 13315–13324 (2007).
pubmed: 17913820 pmcid: 2168887 doi: 10.1128/JVI.01167-07
Leib, D. A. et al. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189, 663–672 (1999).
pubmed: 9989981 pmcid: 2192939 doi: 10.1084/jem.189.4.663
Piper, R. C. & Katzmann, D. J. Biogenesis and function of multivesicular bodies. Annu. Rev. Cell Dev. Biol. 23, 519–547 (2007).
pubmed: 17506697 pmcid: 2911632 doi: 10.1146/annurev.cellbio.23.090506.123319
Trajkovic, K. et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319, 1244–1247 (2008).
doi: 10.1126/science.1153124
Ohanian, J. & Ohanian, V. Sphingolipids in mammalian cell signalling. Cell Mol. Life Sci. 58, 2053–2068 (2001).
pubmed: 11814056 doi: 10.1007/PL00000836 pmcid: 11814056
Spiegel, S. & Merrill, A. H. Jr. Sphingolipid metabolism and cell growth regulation. FASEB J. 10, 1388–1397 (1996).
pubmed: 8903509 doi: 10.1096/fasebj.10.12.8903509 pmcid: 8903509
Tirodkar, T. S. & Voelkel-Johnson, C. Sphingolipids in apoptosis. Exp. Oncol. 34, 231–242 (2012).
pubmed: 23070008 pmcid: 23070008
Utermohlen, O., Herz, J., Schramm, M. & Kronke, M. Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology 213, 307–314 (2008).
pubmed: 18406376 doi: 10.1016/j.imbio.2007.10.016 pmcid: 18406376
Jimenez-Rojo, N., Garcia-Arribas, A. B., Sot, J., Alonso, A. & Goni, F. M. Lipid bilayers containing sphingomyelins and ceramides of varying N-acyl lengths: a glimpse into sphingolipid complexity. Biochim. Biophys. Acta 1838, 456–464 (2014).
pubmed: 24144542 doi: 10.1016/j.bbamem.2013.10.010 pmcid: 24144542
Li, C. M. et al. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics 62, 223–231 (1999).
pubmed: 10610716 doi: 10.1006/geno.1999.5940 pmcid: 10610716
Zupancic, E., Carreira, A. C., de Almeida, R. F. & Silva, L. C. Biophysical implications of sphingosine accumulation in membrane properties at neutral and acidic pH. J. Phys. Chem. B 118, 4858–4866 (2014).
pubmed: 24731183 doi: 10.1021/jp501167f pmcid: 24731183
Crameri, M. et al. MxB is an interferon-induced restriction factor of human herpesviruses. Nat. Commun. 9, 1980 (2018).
pubmed: 29773792 pmcid: 5958057 doi: 10.1038/s41467-018-04379-2
Nicola, A. V. & Straus, S. E. Cellular and viral requirements for rapid endocytic entry of herpes simplex virus. J. Virol. 78, 7508–7517 (2004).
pubmed: 15220424 pmcid: 434080 doi: 10.1128/JVI.78.14.7508-7517.2004
Dohner, K. et al. Importin alpha1 is required for nuclear import of herpes simplex virus proteins and capsid assembly in fibroblasts and neurons. PLoS Pathog. 14, e1006823 (2018).
pubmed: 29304174 pmcid: 5773220 doi: 10.1371/journal.ppat.1006823
Mikloska, Z. & Cunningham, A. L. Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J. Virol. 75, 11821–11826 (2001).
pubmed: 11689663 pmcid: 114768 doi: 10.1128/JVI.75.23.11821-11826.2001
Kim, E. T., White, T. E., Brandariz-Nunez, A., Diaz-Griffero, F. & Weitzman, M. D. SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. J. Virol. 87, 12949–12956 (2013).
pubmed: 24067963 pmcid: 3838123 doi: 10.1128/JVI.02291-13
Gebai, A., Gorelik, A., Li, Z., Illes, K. & Nagar, B. Structural basis for the activation of acid ceramidase. Nat. Commun. 9, 1621 (2018).
pubmed: 29692406 pmcid: 5915598 doi: 10.1038/s41467-018-03844-2
Goni, F. M. & Alonso, A. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim. Biophys. Acta 1758, 1902–1921 (2006).
pubmed: 17070498 doi: 10.1016/j.bbamem.2006.09.011 pmcid: 17070498
Nicola, A. V., McEvoy, A. M. & Straus, S. E. Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 77, 5324–5332 (2003).
pubmed: 12692234 pmcid: 153978 doi: 10.1128/JVI.77.9.5324-5332.2003
Devadas, D. et al. Herpes simplex virus internalization into epithelial cells requires Na+/H+ exchangers and p21-activated kinases but neither clathrin- nor caveolin-mediated endocytosis. J. Virol. 88, 13378–13395 (2014).
pubmed: 25210183 pmcid: 4249063 doi: 10.1128/JVI.03631-13
Cohen, G. H. et al. Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J. Virol. 34, 521–531 (1980).
pubmed: 6154808 pmcid: 288732 doi: 10.1128/JVI.34.2.521-531.1980
Fink, J. & Seibel, J. Click reactions with functional sphingolipids. Biol. Chem. 399, 1157–1168 (2018).
pubmed: 29908120 doi: 10.1515/hsz-2018-0169 pmcid: 29908120
Langlais, D., Barreiro, L. B. & Gros, P. The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation. J. Exp. Med. 213, 585–603 (2016).
pubmed: 27001747 pmcid: 4821649 doi: 10.1084/jem.20151764
Qi, C. F. et al. Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments. Immunol. Res. 45, 62–74 (2009).
pubmed: 18663414 pmcid: 2745513 doi: 10.1007/s12026-008-8032-2
Hu, X. et al. IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res. 71, 2882–2891 (2011).
pubmed: 21487040 pmcid: 3078194 doi: 10.1158/0008-5472.CAN-10-2493
Molony, R. D. et al. Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes. Sci. Signal 10, eaan2392 (2017).
pubmed: 29233916 pmcid: 6429941 doi: 10.1126/scisignal.aan2392
Stohlman, S. A., Woodward, J. G. & Frelinger, J. A. Macrophage antiviral activity: extrinsic versus intrinsic activity. Infect. Immun. 36, 672–677 (1982).
pubmed: 6282756 pmcid: 351282 doi: 10.1128/IAI.36.2.672-677.1982
Xu, Z., Tian, J., Smith, J. S. & Byrnes, A. P. Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J. Virol. 82, 11705–11713 (2008).
pubmed: 18815305 pmcid: 2583672 doi: 10.1128/JVI.01320-08
Maler, M. D. et al. Key role of the scavenger receptor MARCO in mediating adenovirus infection and subsequent innate responses of macrophages. MBio 8, e00670–17 (2017).
pubmed: 28765216 pmcid: 5539421
Stichling, N. et al. Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor. PLoS Pathog. 14, e1006914 (2018).
pubmed: 29522575 pmcid: 5862501 doi: 10.1371/journal.ppat.1006914
Le Blanc, I. et al. Endosome-to-cytosol transport of viral nucleocapsids. Nat. Cell Biol. 7, 653–664 (2005).
pubmed: 15951806 pmcid: 3360589 doi: 10.1038/ncb1269
Nour, A. M., Li, Y., Wolenski, J. & Modis, Y. Viral membrane fusion and nucleocapsid delivery into the cytoplasm are distinct events in some flaviviruses. PLoS Pathog. 9, e1003585 (2013).
pubmed: 24039574 pmcid: 3764215 doi: 10.1371/journal.ppat.1003585
Michen, B. & Graule, T. Isoelectric points of viruses. J. Appl. Microbiol. 109, 388–397 (2010).
pubmed: 20102425 pmcid: 20102425
Olofsson, S. Isoelectric focusing of herpes simplex virus. Arch. Virol. 49, 93–98 (1975).
pubmed: 2144 doi: 10.1007/BF01317529 pmcid: 2144
Jimenez-Rojo, N. et al. Membrane permeabilization induced by sphingosine: effect of negatively charged lipids. Biophys. J. 106, 2577–2584 (2014).
pubmed: 24940775 pmcid: 4070072 doi: 10.1016/j.bpj.2014.04.038
Hafez, I. M., Ansell, S. & Cullis, P. R. Tunable pH-sensitive liposomes composed of mixtures of cationic and anionic lipids. Biophys. J. 79, 1438–1446 (2000).
pubmed: 10969005 pmcid: 1301037 doi: 10.1016/S0006-3495(00)76395-8
Hollenbaugh, J. A. et al. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathog. 9, e1003481 (2013).
pubmed: 23825958 pmcid: 3694861 doi: 10.1371/journal.ppat.1003481
Zhang, K., Lv, D. W. & Li, R. Conserved herpesvirus protein kinases target SAMHD1 to facilitate virus replication. Cell Rep. 28, 449–459 e445 (2019).
pubmed: 31291580 pmcid: 6668718 doi: 10.1016/j.celrep.2019.04.020
Chow, A. Y. & Mellman, I. Old lysosomes, new tricks: MHC II dynamics in DCs. Trends Immunol. 26, 72–78 (2005).
pubmed: 15668121 doi: 10.1016/j.it.2004.11.008 pmcid: 15668121
Geiger, T. et al. Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse. Mol. Cell Proteom. 12, 1709–1722 (2013).
doi: 10.1074/mcp.M112.024919
Ehlert, K. et al. Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr. Rheumatol. Online J. 5, 15 (2007).
pubmed: 17603888 pmcid: 1920510 doi: 10.1186/1546-0096-5-15
Dropulic, L. K. & Cohen, J. I. Severe viral infections and primary immunodeficiencies. Clin. Infect. Dis. 53, 897–909 (2011).
pubmed: 21960712 pmcid: 3189169 doi: 10.1093/cid/cir610
Rehwinkel, J. et al. SAMHD1-dependent retroviral control and escape in mice. EMBO J. 32, 2454–2462 (2013).
pubmed: 23872947 pmcid: 3770946 doi: 10.1038/emboj.2013.163
Sandbaumhuter, M. et al. Cytosolic herpes simplex virus capsids not only require binding inner tegument protein pUL36 but also pUL37 for active transport prior to secondary envelopment. Cell Microbiol. 15, 248–269 (2013).
pubmed: 23186167 doi: 10.1111/cmi.12075 pmcid: 23186167
Yamauchi, Y. et al. The UL14 tegument protein of herpes simplex virus type 1 is required for efficient nuclear transport of the alpha transinducing factor VP16 and viral capsids. J. Virol. 82, 1094–1106 (2008).
pubmed: 18032514 doi: 10.1128/JVI.01226-07 pmcid: 18032514
Krawczyk, A. et al. Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody. Proc. Natl. Acad. Sci. USA 110, 6760–6765 (2013).
pubmed: 23569258 doi: 10.1073/pnas.1220019110 pmcid: 23569258
Henry, B. D. et al. Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice. Nat. Biotechnol. 33, 81–88 (2015).
pubmed: 25362245 doi: 10.1038/nbt.3037 pmcid: 25362245
Walter, T. et al. Incorporation studies of clickable ceramides in Jurkat cell plasma membranes. Chem. Commun. (Camb.) 53, 6836–6839 (2017).
doi: 10.1039/C7CC01220A
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
doi: 10.1073/pnas.0506580102
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).
pubmed: 3037419 pmcid: 3037419 doi: 10.1038/75556
Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).
pubmed: 17076895 pmcid: 17076895 doi: 10.1186/gb-2006-7-10-r100
Gulbins, A. et al. Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide. Mol. Psychiatry 23, 2324–2346 (2018).
pubmed: 30038230 pmcid: 6294742 doi: 10.1038/s41380-018-0090-9
Kachler, K. et al. Enhanced acid sphingomyelinase activity drives immune evasion and tumor growth in non-small cell lung carcinoma. Cancer Res. 77, 5963–5976 (2017).
pubmed: 28883000 doi: 10.1158/0008-5472.CAN-16-3313 pmcid: 28883000

Auteurs

Judith Lang (J)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Patrick Bohn (P)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Hilal Bhat (H)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Holger Jastrow (H)

Institute of Anatomy, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.
Institut for Experimental Immunology and Imaging, Imaging Center Essen, Electron Microscopy Unit, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Bernd Walkenfort (B)

Institut for Experimental Immunology and Imaging, Imaging Center Essen, Electron Microscopy Unit, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Feyza Cansiz (F)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Julian Fink (J)

Institute of Organic Chemistry, Julius-Maximilians University of Würzburg, Am Hubland, Würzburg, D-97074, Germany.

Michael Bauer (M)

Department of Molecular Life Sciences, University of Zurich, Winterthurerstr. 190, CH-8057, Zurich, Switzerland.

Dominik Olszewski (D)

Department of Molecular Life Sciences, University of Zurich, Winterthurerstr. 190, CH-8057, Zurich, Switzerland.

Ana Ramos-Nascimento (A)

Institute of Virology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, D-30625, Germany.

Vikas Duhan (V)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Sarah-Kim Friedrich (SK)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Katrin Anne Becker (KA)

Institute of Molecular Biology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Adalbert Krawczyk (A)

Institute for Virology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.
Department of Infectious Diseases, University Hospital of Essen, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Michael J Edwards (MJ)

Department of Surgery, University of Cincinnati, Cincinnati, OH, USA.

Andreas Burchert (A)

Department of Hematology, Oncology and Immunology, University Hospital Giessen and Marburg, Campus Marburg, Baldingerstr., Marburg, D-35043, Germany.

Magdalena Huber (M)

Institute of Medical Microbiology and Hospital Hygiene, Philipps-University Marburg, Hans-Meerwein Str. 2, Marburg, D-35043, Germany.

Justa Friebus-Kardash (J)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Joachim R Göthert (JR)

Department of Hematology, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Cornelia Hardt (C)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.

Hans Christian Probst (HC)

Institute of Immunology, University Medical Center Mainz, Langenbeckstr. 1, Mainz, D-55131, Germany.

Fabian Schumacher (F)

Institute of Molecular Biology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.
Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert Allee 114-116, Nuthetal, D-14558, Germany.

Karl Köhrer (K)

Biological and Medical Research Center (BMFZ), Heinrich-Heine-University, Universitätsstr. 1, Düsseldorf, D-40225, Germany.

Burkhard Kleuser (B)

Institute of Nutritional Science, University of Potsdam, Arthur-Scheunert Allee 114-116, Nuthetal, D-14558, Germany.

Eduard B Babiychuk (EB)

Institute of Anatomy, University of Bern, Baltzerstr. 4, CH-3012, Bern, Switzerland.

Beate Sodeik (B)

Institute of Virology, Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, D-30625, Germany.
Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Carl-Neuberg-Str. 1, Hannover, D-30625, Germany.

Jürgen Seibel (J)

Institute of Organic Chemistry, Julius-Maximilians University of Würzburg, Am Hubland, Würzburg, D-97074, Germany.

Urs F Greber (UF)

Department of Molecular Life Sciences, University of Zurich, Winterthurerstr. 190, CH-8057, Zurich, Switzerland.

Philipp A Lang (PA)

Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Universitätsstr. 1, Düsseldorf, D-40225, Germany.

Erich Gulbins (E)

Institute of Molecular Biology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany.
Department of Surgery, University of Cincinnati, Cincinnati, OH, USA.

Karl S Lang (KS)

Institute of Immunology, University of Duisburg-Essen, Hufelandstr. 55, Essen, D-45147, Germany. karlsebastian.lang@uk-essen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH